Literature DB >> 12085357

Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites.

José Such1, Rubén Francés, Carlos Muñoz, Pedro Zapater, Juan A Casellas, Ana Cifuentes, Francisco Rodríguez-Valera, Sonia Pascual, Javier Sola-Vera, Fernando Carnicer, Francisco Uceda, José M Palazón, Miguel Pérez-Mateo.   

Abstract

The current pathogenic theory of spontaneous bacterial peritonitis (SBP) in patients with cirrhosis and ascites suggests that repeated episodes of bacterial translocation (BT) from intestinal lumen to mesenteric lymph nodes followed by systemic seeding are the key steps for the final development of infectious events. However, most of the episodes of systemic bacterial circulation remain undetected. Therefore, we investigated the hypothetical presence of bacteria in blood and/or ascitic fluid (AF) from patients with cirrhosis and sterile (culture negative) AF by means of bacterial DNA (bactDNA) detection and identification. Twenty-eight consecutively admitted patients with cirrhosis and presence of AF were included in the study. BactDNA was detected using a polymerase chain reaction (PCR)-based method. The corresponding bacteria were identified by nucleotide sequencing of purified PCR products. BactDNA was detected simultaneously in blood and AF in 9 patients (32.1%). DNA sequencing allowed the identification of Escherichia coli (n = 7) and Staphylococcus aureus (n = 2). In all cases, the similarity between the sequence found in AF and blood indicated that the bactDNA present in both locations originated from a single clone (single translocation event). Child-Pugh score and basic hemodynamic, clinical, endoscopic, and biochemical characteristics were similar among patients with or without the presence of bactDNA. In conclusion, we have detected bactDNA in serum and AF in 32% of all patients studied, and this likely represents single clone episodes of translocation and systemic seeding. E. coli is the most frequently identified bacteria.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12085357     DOI: 10.1053/jhep.2002.33715

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  81 in total

Review 1.  Nitric oxide in patients with cirrhosis and bacterial infections.

Authors:  José Such; Rubén Francés; Miguel Pérez-Mateo
Journal:  Metab Brain Dis       Date:  2002-12       Impact factor: 3.584

2.  Dysfunctional B-cell activation in cirrhosis resulting from hepatitis C infection associated with disappearance of CD27-positive B-cell population.

Authors:  Hiroyoshi Doi; Tara K Iyer; Erica Carpenter; Hong Li; Kyong-Mi Chang; Robert H Vonderheide; David E Kaplan
Journal:  Hepatology       Date:  2012-01-19       Impact factor: 17.425

3.  Early events in spontaneous bacterial peritonitis.

Authors:  B A Runyon
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

4.  Characterisation of bacteria in ascites--reporting the potential of culture-independent, molecular analysis.

Authors:  G B Rogers; L E Russell; P G Preston; P Marsh; J E Collins; J Saunders; J Sutton; D Fine; K D Bruce; M Wright
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-03-18       Impact factor: 3.267

5.  Extracorporeal continuous portal diversion plus temporal plasmapheresis for "small-for-size" syndrome.

Authors:  Peng Hou; Chao Chen; Yu-Liang Tu; Zi-Man Zhu; Jing-Wang Tan
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

6.  Bacterial DNA induces a proinflammatory immune response in patients with decompensated cirrhosis.

Authors:  J Such; C Muñoz; P Zapater; M Pérez-Mateo
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

Review 7.  Gut flora and bacterial translocation in chronic liver disease.

Authors:  John Almeida; Sumedha Galhenage; Jennifer Yu; Jelica Kurtovic; Stephen M Riordan
Journal:  World J Gastroenterol       Date:  2006-03-14       Impact factor: 5.742

Review 8.  Markers of bacterial translocation in end-stage liver disease.

Authors:  Ioannis Koutsounas; Garyfallia Kaltsa; Spyros I Siakavellas; Giorgos Bamias
Journal:  World J Hepatol       Date:  2015-09-18

Review 9.  Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Authors:  Valerio Giannelli; Vincenza Di Gregorio; Valerio Iebba; Michela Giusto; Serena Schippa; Manuela Merli; Ulrich Thalheimer
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Proteomic evidence of bacterial peptide translocation in afebrile patients with cirrhosis and ascites.

Authors:  Rocío Caño; Lucía Llanos; Pedro Zapater; Sonia Pascual; Pablo Bellot; Claudia Barquero; Miguel Pérez-Mateo; José Such; Rubén Francés
Journal:  J Mol Med (Berl)       Date:  2010-01-20       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.